Abstract:Tumor necrosis factor α (TNF-α) is a cytokine that plays a major role in several chronic inflammatory disorders. Anti-TNF-α therapy has been widely employed in clinic. However, the source of natural human TNF-α is so limited that it's difficult to meet the research needs. The purpose of this project is to construct an effective prokaryotic expression system for recombinant human TNF α (rhTNF-α). The sequence of hTNF-α is retrieved from Entrez Gene at NCBI. The whole gene of hTNF-α is optimized, synthezied by a company, inserted into the expression vector pET-28a (+) and expressed in E. coli BL21 (DE3). The N-terminus of hTNF-α contains a His-tag and a TEV protease site. The 10 ×His-tag is used to purify the protein by Ni+-NTA, and the TEV protease site is used to remove the His-tag. The soluble expression conditions of hTNF-α were optimized by orthogonal array design. The large-scale fermentation was carried out under optimized conditions. The expressed rhTNF-α protein was purified by Ni+ affinity chromatography. Then, the 10 ×His tag was removed by TEV protease treatment and followed though Ni+ column again. The purification effect was identified by SDS-PAGE and western blot. The biological activity of rhTNF-α was evaluated by MTT method with L929 cells as target cells. The recombinant cloning and expressing plasmid of rhTNF-α was successfully constructed. The outflow from the Ni column was the purified rhTNF-α, showing single polypeptide band by SDS-PAGE. The productivity of purified rhTNF-α is about 4.17 mg/L. L929 cell cytotoxicity assay showed IC50<10 ng/mL. An effective prokaryotic expression system for rhTNF-α was successfully constructed in our study. The application of two-step Ni+ affinity chromatography purification method could produce soluble rhTNF-α protein with high purity and relative bioactivity.

Construction of Eukaryotic Expression Vector and Establishment of Cell Line Solely Producing Human TNF-alpha in Secretory Form

[Construction and Expression of the Eukaryotic Expression Vector Containing Human Soluble Transforming Growth Factor Beta Receptor II].

Construction of eukaryotic recombinant sTNFR1 plasmid and its inhibitory effects on TNF-α cytotoxicity in vitro

Construction of a Recombinant Eukaryotic Vector Expressing Human Tumor Necrosis Factor Alpha

Expression of Recombinant Human Tumor Necrosis Factor-Α in a Baculovirus Expression System

Expression and Purification of Recombinant Human Tumor Necrosis Factor α in Escherichia Coli

[Cloning, expression and identification of recombinant fusion protein GX1-rmhTNFalpha].

[Construction of Eukarocyte Expression Recombinant of Human Thymosin Alpha1 and Its Influnce to Immune Activity of PBLs Transfected with the Recombinant Pbk-T Alpha1]

Construction of eukaryotic vector of human sTNFR1

Construction of Shuttle, Expression Vector of Human Tumor Necrosis Factor Alpha (Htnf-Α) Gene and Its Expression in a Cyanobacterium, Anabaena Sp. PCC 7120

Production of recombinant porcine tumor necrosis factor alpha in a novel E. coli expression system.

Construction and Expression of Eukaryotic Expression Vector for I Kappa B Alpha Mutant Gene

Expression in Escherichia Coli of Anti-Human Tumor Necrosis Factor Alpha Scfv under the Control of T7 Promoter.

Study of Prokaryotic Expression and Biological Activity of Homo sapiens Kras Protein

Recombinant Expression, Purification and Characterization of Human Soluble Tumor Necrosis Factor Receptor 2.

Active Human and Murine Tumor Necrosis Factor α Cytokines Produced from Silkworm Baculovirus Expression System

[Expression and Secretion of Human Tumor Necrosis Factor Gene Transfected on Human Embryo Myoblasts].

PRODUCTION OF RECOMBINANT PORCINE TUMOR-NECROSIS-FACTOR-ALPHA IN A NOVEL ESCHERICHIA-COLI EXPRESSION SYSTEM

Construction of Eukaryotic Expressing Vector of Human TLT-2 and Establishment of Stable Transfectant L929 Cell Line

Expression and Purification of Human Tumor Necrosis FactorαFusing with Oligo- Histidine

Expression Of A Tnf Inhibitor In Transgenic Mice